Adverum Biotechnologies Inc., of Redwood City, Calif., appointed Laurent Fischer CEO and to its board.
Biovie Inc., of Santa Monica, Calif., appointed Robert Hariri, Steve Gorlin and Sig Rogich to its board.
Bioxcel Therapeutics Inc., of New Haven, Conn., appointed Will Kane executive vice president and chief commercial officer.
Canbridge Pharmaceuticals Inc., of Beijing, appointed Carrie Ann Cook senior vice president, global head of business development.
Cure Pharmaceutical Holding Corp., of Oxnard, Calif., appointed Jonathan Berlent chief business officer.
Macrogenics Inc., of Rockville, Md., appointed Stephen Eck senior vice president, clinical development and chief medical officer, effective July 1, 2020.
Novavax Inc., of Gaithersburg, Md., appointed David Mott to its board.
Nurix Therapeutics Inc., of San Francisco, appointed Michael T. Lotze chief cellular therapy officer, Robert J. Brown vice president of clinical development, Gwenn Hansen chief scientific officer and Hans van Houte chief financial officer.
Zealand Pharma A/S, of Copenhagen, appointed Frank Sanders president of Zealand Pharma U.S., effective July 6, 2020.